Viewing Study NCT02435212


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-26 @ 10:44 PM
Study NCT ID: NCT02435212
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2015-03-17
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-10-21
Start Date Type: ACTUAL
Primary Completion Date: 2018-05-31
Primary Completion Date Type: ACTUAL
Completion Date: 2024-01-15
Completion Date Type: ACTUAL
First Submit Date: 2015-03-17
First Submit QC Date: None
Study First Post Date: 2015-05-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-07-09
Results First Submit QC Date: None
Results First Post Date: 2024-09-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2018-07-24
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-09-02
Last Update Post Date: 2024-09-19
Last Update Post Date Type: ACTUAL